Btobioinnovation.com Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com       SPECIAL REPORT #20.9     COVID-19: A few early lessons.         Western Europe has now become the most active center of the COVID-19 outbreak with around 75,000 confirmed cases, getting close to the 81,000 cases in China, but with already […]

Btobioinnovation.com Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com     Eléments de réponses à ma petite fille qui m’interroge sur le COVID-19.     Les Virus ont-ils un double visage ?       Depuis quelques jours le virus SRAS-COVID-19 occupe toutes nos conversations et son effet pathogène nous est de plus apparent au fur et […]

  Btobioinnovation.com Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com       SPECIAL REPORT #20.8     Slowing down coronavirus by “Flattening the Curve”     Unprecedented efforts are currently ongoing to discover novel vaccines and anti-viral agents and, at the same time, to assess the potential of already existing therapies to fight the fast-increasing […]

  Btobioinnovation.com Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com     SPECIAL REPORT #20.7     Biopharmaceutical Profitability and Costs of R&D Success       Two recent back-to-back articles published in the Journal of the American Medical Association (JAMA) and some immediate comments have attracted our attention.   The first one entitled “Profitability of […]